List your company

SAR & De Novo

Drug discovery and biotech · by META D3

AI powered Drug Discovery and Development platform for drug discovery steps from target identification to clinical trial success, associated with Partex.

Visit website

Where it ranks

Current edition · updated Oct 20, 2026

What it does

AI powered Drug Discovery and Development platform for drug discovery steps from target identification to clinical trial success, associated with Partex.

  • target identification
  • biomarker candidate discovery
  • SAR and de novo molecule generation
  • ADC design
  • PROTAC design
  • antibody engineering
  • indication prioritisation
  • drug reformulation
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
pharma innovators, drug discovery researchers
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

META D3 doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

META D3 hasn't published certifications or security practices for SAR & De Novo that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use SAR & De Novo at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

See the full ranking

  • Chai-2 Platform

    by Chai Discovery

    AI platform for de novo protein design that works reliably.

    #1 in Design molecular candidates

  • DiffuseSandbox

    by Diffuse Bio

    Sandbox for designing novel protein binders, enabling binder design in minutes on a laptop compared to spending weeks in a lab.

    #2 in Design molecular candidates

  • ITO™ Platform

    by 1910

    Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...

    #3 in Design molecular candidates

  • PharmaSphere

    by Receptor.AI

    AI drug design platform with dedicated sub-platforms for Small Molecules, Peptides, and Proximity Inducers, combining 40+ experimentally validated AI methodologies for molecular...

    #4 in Design molecular candidates

  • DeepChain Labs

    by DeepChain

    Experimental interface for multi-objective optimisation and interactive conditioning for flexible antibody design.

    #5 in Design molecular candidates

  • DrugFlow Platform

    by DrugFlow

    AI-driven one-stop new drug discovery platform with proprietary core algorithms covering the entire drug discovery process, including target discovery, lead compound discovery,...

    #6 in Design molecular candidates

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim SAR & De Novo